methylprednisolone has been researched along with Dyskinesia, Medication-Induced in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, N; Kikuchi, T; Matsumoto, A; Mikuni, N; Miyamoto, S; Yamada, S; Yokoyama, Y | 1 |
1 trial(s) available for methylprednisolone and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Intravenous methylprednisolone reduces the risk of propofol-induced adverse effects during Wada testing.
Topics: Adolescent; Adult; Aged; Anesthetics, Intravenous; Carotid Arteries; Cerebral Cortex; Chi-Square Distribution; Child; Diagnostic Techniques, Neurological; Dominance, Cerebral; Dyskinesia, Drug-Induced; Female; Humans; Male; Methylprednisolone; Middle Aged; Muscle Tonus; Neuroprotective Agents; Premedication; Propofol; Treatment Outcome; Young Adult | 2010 |